While it’s encouraging to know the Pfizer vaccine seems to be impervious to the effects of at least one significant mutation, many more remain in the mix that we’re still unsure about.
Category: pharma & healthcare
Genome Sequencing In The United States, Or Lack Thereof
The US and other countries should follow the UK and South Africa’s footsteps in terms of revamped genome sequencing regimes, as the next variant may be hiding in our backyard.
How The Covid-19 Virus Changes
New variants of SARS-CoV-2 are sweeping the world. But how do they form in the first place?
The Risks Of Delaying Or Diluting Covid-19 Vaccines
Diluting the vaccine or delaying the second dose is a reckless move, which may give SARS-CoV-2 an opportunity to mutate beyond the power and protection of our current set of vaccines.
New Covid-19 Variants In One Country Pose A Threat To All Countries
SARS-CoV-2 variants cause problems for the afflicted countries and present dangers for all countries in the battle against Covid-19.
One In Fifty People In England Had Covid-19 Last Week, According To New Data
The number rises to 1 in 30 people in the capital London as the U.K. reported another day of record coronavirus case numbers.
Vaccines Need To Be Cheap And Accessible Worldwide
Vaccines need to be affordable and accessible, not just in the United States, but globally. As one of the world’s wealthiest countries, we should do our part to ensure we achieve worldwide vaccination.
Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs
While net costs of insulin to PBMs and payers have decreased in recent years, owing to steep rebates, these savings have not necessarily been passed through to patients. Patients are either paying the full retail price if uninsured or in the deductible…
Specialty Generics Face A Maze Of Perverse Incentives In Medicare Part D
Specialty generics haven’t gained the kind of traction in Medicare Part D that one would expect. This includes specialty generics such as imatinib mesylate and glatiramer acetate. The current set-up of the Medicare Part D benefit sends the wrong price …
Covid-19 Vaccination’s Bumpy Rollout In The U.S.
Inoculation programs are informed by a carefully planned system for distributing vaccines as effectively and equitably as possible. A lesson to be drawn from the bumpy vaccine rollout is that federal assistance is needed to help states establish and ma…
